We are live on ! Find out more
APEN

Apollo Endosurgery

Delisted

APEN was delisted on the 3rd of April, 2023.

11 hedge funds and large institutions have $111K invested in Apollo Endosurgery in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

3.75% less ownership

Funds ownership: 5.9% → 2.15% (-3.7%)

45% less funds holding

Funds holding: 20 → 11 (-9)

69% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 13

72% less capital inflows, than outflows

Capital inflows: $88.5K | Capital outflows: $314K

Holders
11
Holders Change
-9
Holders Change %
-45%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
1
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

APEN Hedge Fund Activity: Q2 2016 in Review

11 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery (APEN) for Q2 2016, worth a combined $111K — down 69% from $362K a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of APEN and 4 opened new positions — a net loss of 9 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Renaissance Technologies, adding an estimated $77.5K. The largest seller was Sabby Management, exiting entirely with an estimated $206K sold.

  • 11 institutional investors held Apollo Endosurgery (APEN) as of Q2 2016, down from 20 in Q1 2016.
  • Funds reported $111K of Apollo Endosurgery stock for Q2 2016, down 69% quarter-over-quarter.
  • 4 funds opened new Apollo Endosurgery positions in Q2 2016 and 13 closed out, a net change of -9 holders.
  • The largest Apollo Endosurgery buyer in Q2 2016 was Renaissance Technologies, an estimated $77.5K added.
  • The largest Apollo Endosurgery seller in Q2 2016 was Sabby Management, an estimated $206K sold.

Based on aggregated 13F filings for Q2 2016.